Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07350499 · ClinicalTrials.gov registry record

Aspiration Thrombectomy Using the Symphony or Prodigy System

A clinical trial of Pulmonary Embolism and Venous Thromboembolism, sponsored by Imperative Care.

Recruiting
Registry status
750
Enrollment target
1
Study location

NCT07350499 is a study of Pulmonary Embolism and Venous Thromboembolism that is actively recruiting participants, run by Imperative Care. The registered enrollment target is 750 participants, below the 3,043-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07350499, a study of Pulmonary Embolism and Venous Thromboembolism, is actively recruiting participants, sponsored by Imperative Care.

RECRUITING
Registry status
750 participants
Enrollment target
1
Study location

Study Summary

The study is designed to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used in endovascular procedures across the peripheral or pulmonary vasculature.

Interventions

  • DEVICE Prodigy Thrombectomy System
  • DEVICE Symphony Thrombectomy System

Study Locations (1)

Alabama

  • Huntsville Hospital - Huntsville

Trial Details

FieldValue
Enrollment Target 750 participants
Start Date 2026-01-23
Est. Completion 2030-09

Sponsor

Imperative Care

4 total trials

What the Registry Record Tells You About NCT07350499

The ClinicalTrials.gov registry entry for NCT07350499 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,043-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (75% lower). The listed sponsor is Imperative Care, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions - of which Prodigy Thrombectomy System is the first listed.

NCT07350499 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT07350499 about?

NCT07350499 is a clinical study titled "Aspiration Thrombectomy Using the Symphony or Prodigy System". The study is designed to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used in endovascular procedures across the peripheral or pulmonary vasculature.

What is the current status of trial NCT07350499?

This trial is currently recruiting. The enrollment target is 750 participants. The study started on 2026-01-23. Estimated completion is 2030-09.

What conditions does trial NCT07350499 study?

This clinical trial studies the following conditions: Pulmonary Embolism, Venous Thromboembolism, Arterial Thromboembolism.

What interventions are being tested in trial NCT07350499?

The interventions under investigation include: Prodigy Thrombectomy System (DEVICE), Symphony Thrombectomy System (DEVICE).

Who is sponsoring clinical trial NCT07350499?

This trial is sponsored by Imperative Care, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07350499 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Embolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.